Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.

Liang-Peng Sun,Li-Xin Gao,Wei-Ping Ma,Fa-Jun Nan,Jia Li,Hu-Ri Piao
DOI: https://doi.org/10.1111/j.1747-0285.2012.01431.x
2012-01-01
Chemical Biology & Drug Design
Abstract:A series of 2,4,6-trihydroxychalcone derivatives were synthesized and identified as reversible and competitive protein tyrosine phosphatase (PTP) 1B inhibitors with IC50 values in the micromolar range. Compound 4a had the greatest in vitro inhibition activity against PTP1B (IC50 = 0.27 +/- 0.01 mu m) and the best selectivity (6.9-fold) for PTP1B relative to T-cell protein tyrosine phosphatases. The compounds identified herein provide a foundation on which to design specific inhibitors of PTP1B and other PTPs.
What problem does this paper attempt to address?